home / stock / hbpcf / hbpcf news

HBPCF News and Press, Helix Biopharma Corp

Stock Information
Company Name: Helix Biopharma Corp
Stock Symbol: HBPCF
Market: OTC
Website: helixbiopharma.com
Menu
HBPCF HBPCF Quote HBPCF Short HBPCF News HBPCF Articles HBPCF Message Board
Get HBPCF Alerts

News, Short Squeeze, Breakout and More Instantly...
HBPCF - Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC London

(TheNewswire)   Toronto, Ontario – TheNewswire - February 24, 2026 – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical...
HBPCF - Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases

(TheNewswire) (Toronto, Ontario; February 5, 2026) – TheNewswire - Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage oncolog...

HBPCF - Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025

(TheNewswire) Toronto, Ontario – TheNewswire - 15 December, 2025 – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company&#...

HBPCF - Helix Biopharma GAAP EPS of -$0.09

2025-10-29 17:49:42 ET More on Helix BioPharma Corp. Seeking Alpha’s Quant Rating on Helix BioPharma Corp. Financial information for Helix BioPharma Corp. Read the full article on Seeking Alpha For further details see: Helix Biopharma GAAP EPS of -...
HBPCF - Helix BioPharma Corp. Announces Fiscal 2025 Year-End Results

(TheNewswire) Toronto, Ontario – TheNewswire - 29 October 2025 – Helix BioPharma Corp. (TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a clinic...

HBPCF - Expected US Company Earnings on Thursday, October 23rd, 2025

Escalade Incorporated (ESCA) is expected to report for Q3 2025 FTI Consulting Inc. (FCN) is expected to report $1.93 for Q3 2025 Valley National Bancorp (VLY) is expected to report $0.26 for Q3 2025 Popular Inc. (BPOP) is expected to report $3.04 for Q3 2025 Onward Holdings Co., L...

HBPCF - Helix BioPharma Responds to Market Activity

(TheNewswire) Toronto, Ontario – TheNewswire - 6 October 2025 – Helix BioPharma Corp. (TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a clinica...
HBPCF - Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025

TORONTO, ON / ACCESS Newswire / September 9, 2025 / Helix BioPharma Corp. (TSX:HBP)(OTC:HBPCF)(FRANKFURT:HBP0) ( "Helix" or the "Company" ), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vincible, is pleased to announce that the Company wil...

HBPCF - Helix BioPharma Concludes Review, Will Not Proceed with Proposed Equity Draw-Down Subscription Facility with GEM

(TheNewswire) Toronto, Ontario – TheNewswire - 5 September 2025 – Helix BioPharma Corp. (TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a clini...

HBPCF - Helix Biopharma Corp. Announces Publication in Frontiers in Oncology on the Effects of L-DOS47 as Monotherapy in NSCLC

(TheNewswire) Toronto, Ontario – TheNewswire - 13 August 2025 – Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “HBPCD”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a cl...
Next 10